Reuters logo
BRIEF-Rigel Pharmaceuticals enters into amendment to controlled equity offerings sales agreement
2017年5月30日 / 晚上8点52分 / 4 个月前

BRIEF-Rigel Pharmaceuticals enters into amendment to controlled equity offerings sales agreement

May 30 (Reuters) - Rigel Pharmaceuticals Inc

* Entered into amendment no. 1 to controlled equity offerings sales agreement, dated august 18, 2015 - SEC filing

* Co may offer and sell through Cantor additional shares of co’s common stock, having aggregate offering price of up to $40.0 million Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below